More Posts

Myths about Alzheimer’s cures and what you can try instead

7 by / on 13 Apr 2014, / in dementia

Have you had one of those nasty moments recently when it is clear that your memory is failing? Confidently rushing up stairs to get something then realising you have no idea what it was; meeting someone you know perfectly well and being unable to remember their name. A few of these moments and a name that none of us forgets comes all too easily to mind: Alzheimer’s…. (Read more…)

Statin advice from the Wizard of Oz

9 by / on 25 Mar 2014, / in statins

There is a whiff of the Wizard of Oz about the advice on statins that we’ve been getting for years. It comes in the form of ringing pronouncements from behind a curtain that all is well… (Read more…)

Why Very Low Calorie Diets (VLCD) won’t solve the diabetes crisis

72 by / on 12 Mar 2014, / in low carb diet

What’s the best way to eat if you want to stay a healthy weight and lower your risk of various chronic disorders? That’s the big question behind the long running diet war between an embattled low fat establishment and those in my gang – the low carb/high fat rebels. (Read more…)

SOS: Sanity over Statins – CTT the house of statin secrets

8 by / on 4 Mar 2014, / in statins

Should a professional body, however eminent, be allowed to keep information about the safety of products they are supplying to public hidden so no one else can run tests on them? (Read more…)

SOS: Sanity over Statins – Sssssh Side effects, pharma’s fingers and a cunning plan

0 by / on 4 Mar 2014, / in statins

HealthInsightUK has a number of contributors who are experts in statins. Here three of them – Dr John Briffa, Zoë Harcombe and Aidan Goggins respond to the CTT investigation. They explain why side-effect data is unreliable and disagree about whether it is in the drug companies interest that the risk of side-effects is downplayed or is that part of cunning plan? (Read more…)

So you’ve survived cancer – that’s only the beginning

11 by / on 28 Feb 2014, / in cancer

Like returning soldiers cancer survivors are usually given some sort of victory celebration. But as with soldiers for far too many that is just the beginning of a new and much more lonely set of personal battles. About a quarter of cancer survivors – 500.000 people in the UK – are dealing with the long term fall out from their treatment. (Read more…)

Statins: just say no. Sensible reasons why they are stupid medicine

10 by / on 17 Feb 2014, / in statins

Increasingly people are questioning whether it’s worth taking statins, the cholesterol-lowering drugs that are supposed to cut your risk of developing heart disease. We think they are a really bad idea, unless you’ve already got heart disease, and have explained why… (Read more…)

Drug killing 10,000 in UK every year. How could you tell?

3 by / on 12 Feb 2014, / in evidence based medicine

Last week an email containing what looked like a great story arrived in my inbox – drug kills 800,000 in Europe in 5 years! A quick check revealed that that this was no wild or dodgy claim. It was based on research by a cardiologist at Imperial College Professor Darryl Francis, just published in the European Heart Journal.(Read more…)

How the TV bout Sugar vs. Fat was rigged

41 by / on 30 Jan 2014, / in low carb diet

Just how accurate and informative was BBC2’s Horizon program on Wednesday that aimed at scientifically answering the question: which is more deadly: Eating lots of sugar or lots of fat? The format was to feed two doctors who were also identical twins – Alex and Chris – unlimited amounts of one or the other. Alex got a low carb/high fat diet while Chris followed the traditional low fat/high carb diet with added the sugar. (Read more…)

Science and the great biomedical lottery

6 by / on 22 Jan 2014, / in evidence based medicine

Unfortunately for the rest of us today’s medical research is not driven by an abstract search for objective truth but by the need to produce a product. Unless there is a drug at the end of promising new line of research it’s unlikely to attract funding from the biggest payers – the drug companies. Instead it will be parked with the comment that it needs more research, the funding for which will be virtually impossible to obtain, however effective it is. (Read more…)

WP-Backgrounds by InoPlugs Web Design and Juwelier Schönmann